XML 22 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
Investment in Unconsolidated Subsidiaries (Details Textual) (USD $)
0 Months Ended 1 Months Ended 3 Months Ended
May 31, 2014
May 31, 2014
Mar. 31, 2015
Mar. 31, 2014
Dec. 31, 2014
Dec. 31, 2013
Jul. 07, 2014
Jun. 30, 2014
Mar. 31, 2011
Schedule Of Equity Method Investments [Line Items]                  
Joint venture owned by the entity         49.90%us-gaap_EquityMethodInvestmentOwnershipPercentage        
Sale of stock, number of shares 2,000,000us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction                
Sale of stock, price per share $ 1.50us-gaap_SaleOfStockPricePerShare $ 1.50us-gaap_SaleOfStockPricePerShare              
Sale of stock, value $ 3,000,000us-gaap_SaleOfStockConsiderationReceivedOnTransaction                
Net proceeds received in joint venture   10,000,000us-gaap_ProceedsFromIssuanceOrSaleOfEquity              
Education Joint Venture                  
Schedule Of Equity Method Investments [Line Items]                  
Gain (Loss) on Earnings from joint venture     (4,215)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_EducationJointVentureMember
(3,416)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_EducationJointVentureMember
         
Income (loss) on joint venture     4,215us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_EducationJointVentureMember
3,415us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_EducationJointVentureMember
         
Percentage of gain/loss on joint venture     50.00%mlss_EquityMethodInvestmentSummarizedFinancialInformationPercentageOfNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_EducationJointVentureMember
50.00%mlss_EquityMethodInvestmentSummarizedFinancialInformationPercentageOfNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_EducationJointVentureMember
         
Investment in joint venture     19,977us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_EducationJointVentureMember
  24,192us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_EducationJointVentureMember
       
Milestone China                  
Schedule Of Equity Method Investments [Line Items]                  
Joint venture owned by the entity               40.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= country_CN
 
Income (loss) on joint venture     96,674us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= country_CN
           
Percentage of gain/loss on joint venture     40.00%mlss_EquityMethodInvestmentSummarizedFinancialInformationPercentageOfNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= country_CN
           
Investment in joint venture     445,325us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= country_CN
  348,651us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= country_CN
  1,000,000us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= country_CN
1,000,000us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= country_CN
 
Distributor price per instrument               $ 1,295mlss_DistributorPricePerInstrument
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= country_CN
 
Milestone China | Net Income Loss                  
Schedule Of Equity Method Investments [Line Items]                  
Income (loss) on joint venture     241,696us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_IncomeStatementLocationAxis
= mlss_NetIncomeLossMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= country_CN
           
Medical Joint Venture                  
Schedule Of Equity Method Investments [Line Items]                  
Contribution of Milestone in joint venture     1,500,000us-gaap_TechnologyServicesCosts
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
           
Capital contribution     1,500,000us-gaap_ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
           
Joint venture owned by the entity                 50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
Contribution of Milestone in joint venture     507,000us-gaap_FiniteLivedLicenseAgreementsGross
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
           
Number Of Development Of Instruments     2mlss_NumberOfDevelopmentOfInstruments
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
           
Sale of stock, number of shares           2,000,000us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
     
Sale of stock, price per share     $ 0.45us-gaap_SaleOfStockPricePerShare
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
    $ 1.50us-gaap_SaleOfStockPricePerShare
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
     
Sale of stock, value           3,000,000us-gaap_SaleOfStockConsiderationReceivedOnTransaction
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
     
Net proceeds received in joint venture           2,363,000us-gaap_ProceedsFromIssuanceOrSaleOfEquity
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
     
Percentage of ownership after transaction     49.98%us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
45.50%us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
49.98%us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
       
Purchase of additional shares         995,000us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
       
Purchase of additional shares, value         447,750us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativeProceedsReceivedOnAllTransactions
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
       
Gain (Loss) on Earnings from joint venture     (450,160)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
(130,523)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
         
Legal expenses related to marketing clearance     45,000us-gaap_LegalFees
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
39,153us-gaap_LegalFees
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
         
Investment in Milestone Medical Inc     506,947us-gaap_CostMethodInvestments
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
852,295us-gaap_CostMethodInvestments
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
         
Reimbursable expense included in account receivable, net     162,214us-gaap_AccountsReceivableRelatedParties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
48,641us-gaap_AccountsReceivableRelatedParties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
         
Other charges     246,505us-gaap_OtherExpenses
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
24,553us-gaap_OtherExpenses
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
         
Medical Joint Venture | Private Placement                  
Schedule Of Equity Method Investments [Line Items]                  
Percentage of ownership before transaction           50.00%us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
/ us-gaap_SubsidiarySaleOfStockAxis
= us-gaap_PrivatePlacementMember
     
Percentage of ownership after transaction           45.50%us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
/ us-gaap_SubsidiarySaleOfStockAxis
= us-gaap_PrivatePlacementMember
     
Gain on dilution effect           $ 1,363,650us-gaap_GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= mlss_MedicalJointVentureMember
/ us-gaap_SubsidiarySaleOfStockAxis
= us-gaap_PrivatePlacementMember